Hemispherian Oncology
Innovative therapeutics for aggressive brain tumors
Tell me more

Mission

Our mission is to improve the lives of adults and children afflicted with an agressive brain tumor.

  • Brain Cancer and Treatments

    Glioblastoma multiforme is the most prevalent and aggressive malignant tumor of the central nervous system. Currently available treatments do not have the desired impact and only marginally improve life expectancy. Glioblastoma multiforme has one of the highest unmet needs in oncology.

  • Our Solution

    We have identified two compounds that specifically and selectively kill glioblastoma multiforme cells. Models have shown that tumors are regressing to the point where there is no tumor mass identifiable. These drugs are well tolerated in animal models and are expected to be well tolerated in humans.

  • The Market

    n 2014, a combined 84,704 cases of glioblastoma multiform were diagnosed in France, Germany, Italy, Spain, UK, US and Japan. Glioblastoma multiforme is the 17th most common cancer and the second most common cancer in children. The majority of glioblastoma multiforme tumors are resistant to the frontline chemotherapeutic drug. There is no standard second line treatment.

  • Our Partners

    We are collaborating with neurosurgeons, chemists, and international contract research organizations.

  • The next Step

    We are actively looking for partners and investors. If you are interested in working with us, or if you would like more information about our cause please contact us below.

  • Be part
    of our
    quest!

Our team

We are a company of scientists, engineers and entrepreneurs working together for many years.

Dr. Adam Robertson

Dr. Adam Robertson

Adam Robertson is a biochemist and currently a group leader at Oslo University Hospital.

Dr. Pierre Chymkowitch

Dr. Pierre Chymkowitch

Pierre Chymkowitch is a biologist and a group leader at Oslo University Hospital. He is also Co-Founder and CSO of Hemispherian AS.

Pierre Rossi

Pierre Rossi

Pierre Rossi is a computer scientist and entrepreneur. He is also Co-Founder and CTO of Hemispherian AS.

Zeno Albisser

Zeno Albisser

Zeno Albisser is a computer scientist and entrepreneur. He is also Co-Founder and CEO of Hemispherian AS.

Contact us

Postal Address

Hemispherian Oncology
Gaustadalléen 21
NO-0349 Oslo
Norway

Phone & E-Mail

+47 406 03 455
info@hemispherian.com